GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Codon AG (HAM:CNW) » Definitions » YoY EBITDA Growth

Codon AG (HAM:CNW) YoY EBITDA Growth : 7.85% (As of Jun. 2022)


View and export this data going back to 1990. Start your Free Trial

What is Codon AG YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Codon AG's YoY EBITDA Growth for the quarter that ended in Jun. 2022 was 7.85%.

Codon AG's EBITDA per Share for the six months ended in Jun. 2022 was €-0.22.

Codon AG YoY EBITDA Growth Historical Data

The historical data trend for Codon AG's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Codon AG YoY EBITDA Growth Chart

Codon AG Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -64.27 75.89 -412.59 -26.88 66.88

Codon AG Semi-Annual Data
Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.89 34.66 38.73 69.48 7.85

Codon AG YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Codon AG's YoY EBITDA Growth for the fiscal year that ended in Dec. 2021 is calculated as:

YoY EBITDA Growth (A: Dec. 2021 )
=(EBITDA per Share (A: Dec. 2021 )-EBITDA per Share (A: Dec. 2020 ))/ | EBITDA per Share (A: Dec. 2020 ) |
=(-0.308--0.93)/ | -0.93 |
=66.88 %

Codon AG's YoY EBITDA Growth for the quarter that ended in Jun. 2022 is calculated as:

YoY EBITDA Growth (Q: Jun. 2022 )
=(EBITDA per Share (Q: Jun. 2022 )-EBITDA per Share (Q: Jun. 2021 )) / | EBITDA per Share (Q: Jun. 2021 )) |
=(-0.223--0.242)/ | -0.242 |
=7.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Codon AG YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Codon AG's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Codon AG (HAM:CNW) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Codon AG (HAM:CNW) » Definitions » YoY EBITDA Growth
Comparable Companies
XTER:T3T1 XTER:PDA XTER:UMDK FRA:TIS STU:QS6A OCSE:NOVO B VRTX REGN ASX:CSL SGEN MRNA XKRX:207940 XBRU:ARGX BNTX HKSE:02269 OCSE:GMAB ALNY BGNE XBRU:UCB BMRN
Traded in Other Exchanges
N/A
Address
Warthestrasse 21, Teltow, DEU, 14513
Website
http://www.codon.de
Codon AG develops, produces and distributes autologous cell therapies for the minimally invasive repair of cartilage defects. The product being marketed is a cell therapy product for the minimally invasive treatment of cartilage damage in the knee joint that uses only the patient's own cartilage cells (autologous chondrocytes). CODON's method is currently used in over 200 clinics in Germany and more than 14,000 patients have already been treated.